4 | Good | NO2 | None | None |
35 | Good | O3 | None | None |
158 | Unhealthy | PMSC | Increased aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults; increased respiratory effects in general population | People with heart or lung disease, older adults, and children and the groups at most risk. |
59 | Moderate | PM2.5LC_BAM | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children are the groups most at risk. |
4 | Good | NO2 | None | None |
36 | Good | O3 | None | None |
156 | Unhealthy | PMSC | Increased aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults; increased respiratory effects in general population | People with heart or lung disease, older adults, and children and the groups at most risk. |
74 | Moderate | PM2.5LC_BAM | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children are the groups most at risk. |
2 | Good | NO2 | None | None |
155 | Unhealthy | PMSC | Increased aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults; increased respiratory effects in general population | People with heart or lung disease, older adults, and children and the groups at most risk. |
134 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
3 | Good | NO2 | None | None |
128 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
2 | Good | NO2 | None | None |
127 | Unhealthy for Sensitive Groups | PMSC | Increasing likelihood of respiratory symptoms in sensitive individuals, aggravation of heart or lung disease and premature mortality in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |